Skip to main content

Table 2 Comparison of clinical and economical parameters

From: Analysis of the cost-efficiency of the vascular impulse technology (VIT) in the perioperative management of complex ankle fractures: results of a prospective randomised controlled trial

 

VIT

Control

p-Value

Length of stay (d)

ITT

16.8 (5.3)

20.8 (9.0)

0.101

AT

17.1 (4.6)

20.0 (9.1)

0.214

Revenues (TEUR)

ITT

12.6 (4.4)

12.8 (7.0)

0.921

AT

13.2 (4.3)

12.2 (6.8)

0.620

Costs (TEUR)

ITT

9.6 (2.7)

11.8 (5.9)

0.140

AT

9.6 (2.5)

11.6 (5.7)

0.189

Contribution margin (TEUR)

ITT

2.9 (3.2)

0.9 (3.6)

0.0732

AT

3.6 (2.9)

0.7 (3.4)

0.0082

  1. Significant p-value is displayed in bold
  2. Values are presented in means with (standard deviation). p-values are calculated using Student's t test for independent samples with Welch's correction. ITT Intention-to-treat, AT as treated
  3. 2Significance level was set at p < 0.05